A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab.
- Resource Type
- Article
- Source
- Journal of Neurosurgery; May2018, Vol. 128 Issue 5, p1419-1427, 9p
- Subject
- Language
- ISSN
- 00223085